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Hypocitraturia is one of the major risk factors for nephrocalci- is still a matter of debate, although it is definitively multi-
nosis in very low birth weight (VLBW) infants. factorial [3–5]. Since Hufnagle et al [6] described the
Background. Very low birth weight (VLBW) infants are at association between long-term furosemide therapy andrisk to develop nephrocalcinosis (NC). NC may result from
renal calcifications in preterm infants, additional clinicalspontaneous or therapy-induced imbalance between promoters
predisposing factors like other medications (e.g., dexa-and inhibitors of crystallization in the urine. However, data on
“normal” urinary excretions of these parameters in VLBW methasone, methylxantine), parenteral nutrition, long-
infants are sparse. Therefore, we prospectively examined the term ventilation, oxygen dependency, decreased urine
urinary excretion of calcium, oxalate, uric acid, and citrate in
output, and a lower gestational age have been incrimi-VLBW infants during the first 8 weeks of life.
nated [1, 3–5]. Long-term follow-up in VLBW infantsMethods. Urine samples were collected once weekly in 124
VLBW infants. NC appeared in 16 infants, whose data were with NC had shown specific morbidity, with NC leading
separately analyzed. The remaining 108 infants were divided to a decline of glomerular filtration rate (GFR) or to an
into subgroups: A, 1000 g (N  53); and B, 1000 to 1500 g impairment of tubular function [7, 8].(N 55). Random urine samples were analyzed and the results
NC is mostly due to either parenchymal calcium oxa-were expressed as molar creatinine ratios. Calcium/citrate and
late or calcium phosphate deposition [6, 9]. Therefore, NCoxalate/citrate expressed the risk for calcium oxalate crystalli-
zation. is considered to result, in analogy to the pathogenesis of
Results. In group A, citrate excretion was lower at weeks 2 urinary stone formation, from a spontaneous or therapy-
to 5 and 7; calcium/citrate was higher in weeks 2, 4, and 7;
induced imbalance between promotors (e.g., calcium,oxalate/citrate was higher in weeks 3, 4, 7, and 8; and calcium/
oxalate, uric acid) and inhibitors (e.g., citrate, magne-creatinine ratio was higher in week 4 (P  0.05). Citrate/cre-
atinine ratios were low in nine infants with NC. Oxalate/creati- sium) of crystallization in the urine [4, 10]. Hence, evalu-
nine and calcium/creatinine were elevated in five and calcium/ ation of these parameters seems to be helpful to assess
citrate was increased in nine infants with NC. the risk of NC and to eventually prevent it in this popula-Conclusion. Hypocitraturia is a major risk factor for NC
tion. However, apart of one report about urinary oxalatein VLBW infants, especially in those 1000 g. The urinary
excretions in VLBW infants seem to depend on birth weight, excretion, there are no suitable longitudinal data on the
age, and clinical condition. Hence, supplementation with alkali excretion of lithogenic and inhibitory substances in
citrate may have a beneficial effect in the prevention of NC. VLBW infants [11]. Therefore, we prospectively exam-
ined the urinary excretion of calcium, oxalate, uric acid,
and citrate in the population of VLBW infants during
Premature infants are known to have an increased the first 8 weeks of life. In addition, a group of smaller,
risk for the development of nephrocalcinosis (NC). The
less mature infants was compared to a group of larger,
incidence is particularly high in infants with a very low
more mature infants, as we expected significantly differ-birth weight (VLBW; 1500 g), but data published var-
ent urinary concentrations of promotors/inhibitors ofied between 1.7% and 65% [1, 2]. The etiology of NC
crystal formation in either group.
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collections for analysis of lithogenic and stone-inhibitory cinosis [12]. The study was approved by the local ethics
committee and written consent was obtained by the par-parameters were started in all infants using plastic bags
(girls, boys) or 10 mL vials (boys). However, satisfactory ents before urine sampling. For statistical analysis, the
Mann-Whitney and Kruskal-Wallis tests were performedurine collections (more than four samples) during the
first 8 weeks of life could only be obtained in 124 VLBW using SPSS Software (SPSS, Chicago, IL, USA). P values
of less than 0.05 were considered to be significant.infants (median birth weight, 1015 g; range, 380 to 1500 g)
of 34 weeks gestation age (median, 29 weeks; range,
21 to 34 weeks). This was due to patient reasons (e.g.,
RESULTS
problems attaching plastic bags for urine collections due
The clinical data obtained in the preterm infants exam-to vulnerable skin), or early discharge of the preterm
ined are shown in Table 1. The time of mechanical venti-infants to secondary hospitals nearby the parents’ homes.
lation and the dosage of specific medication was signifi-In addition, infants with renal anomalies, or renal insuf-
cantly higher in the infants of group A and those withficiency, as well as infants with gastrointestinal or cardio-
NC compared to the more mature infants of group Blogic diseases, were excluded from the study.
(P  0.01). There was no significant difference betweenTotal parenteral nutrition was started in all infants on
group A and the infants with NC. No infant had prolongedthe second day of life with 4 g/kg body weight glucose and
acidosis for more than 4 to 6 hours. The urinary molar cal-0.5 g/kg protein and was increased to the final amount of
cium/creatinine, oxalate/creatinine, uric acid/creatinine, ci-12 g/kg glucose and 2.5 g/kg protein at the end of the
trate/creatinine, calcium/citrate, and oxalate/citrate ratiosfirst week. Thereafter, it was tapered in favor of oral
in preterm infants with birth weight 1000 g (group A)nutrition. Feeding was entirely oral at the end of the
and 1000 to 1500 g (group B) during the first 8 weekssecond week of life. Calcium intake of the preterm in-
of life are shown in Tables 2 and 3, respectively. Despitefants was adjusted to 120 mg/kg body weight/day and
all efforts we were unable to obtain a complete weeklyphosphorus intake to 70 mg/kg body weight/day.
series in every infant, hence the number of weekly urineAs we wanted to estimate “normal” values of the ex-
analyses varies.cretion parameters, urine specimen from 16 infants who
Because the values were non-normally distributed, theydeveloped NC (median birth weight, 770 g; range, 415
are expressed as median values and the range. We ob-to 1450 g) were separately analyzed. Hence, a total of 108
served a definite effect of age on all ratios. In generalpreterm infants (57 girls and 51 boys) were included into
calcium/creatinine, oxalate/creatinine, and citrate/creati-the study to obtain data appropriate to use as normal levels
nine ratios were lower in the first 3 weeks of life thanin this group of infants. To evaluate the influence of the
in weeks 6 to 8. The ratios of urinary citrate increasedbirth weight on the urinary parameters examined, the in-
over time. The median values for uric acid/creatinine,fants were subsequently divided into subgroup A with 53
calcium/citrate, and oxalate/citrate ratios were relativelyinfants 1000 g birth weight (median, 717 g; range, 380
constant. There were no specific differences with regardto 990 g) and subgroup B with 55 infants weighing 1000
to sex for any variable. As compared to group B, theto 1500 g at birth (median, 1306 g; range, 1010 to 1500 g).
smaller infants (group A) had lower citrate/creatinineCalcium, oxalate, citrate and, since the year 2000, uric
excretions, which reached significance in weeks 2 to 5acid concentrations were weekly analyzed in random urine
and 7 (P  0.05) (Fig. 1C). Furthermore, infants fromsamples, and the results were correlated to creatinine ex-
group A had higher calcium/citrate ratios in weeks 2, 4,cretion. To evaluate the risk for calcium oxalate crystalli-
and 7 (P  0.05) (Fig. 1E) and higher oxalate/citratezation, calcium/citrate and oxalate/citrate ratios were cal-
ratios in weeks 3, 4, 7, and 8 (P  0.05) (Fig. 1F). Inculated. Calcium concentration was measured by atomic
contrast, there was no systematic difference concerningabsorption spectroscopy (EFOX, Eppendorf, Germany),
the calcium/creatinine, oxalate/creatinine, and uric acid/oxalate, citrate, and uric acid concentrations were mea-
creatinine ratios.sured enzymatically using oxalate oxidase (Sigma, Tauf-
The infants who developed NC had the lowest urinarykirchen, Germany), citrate lyase and the uricase method
citrate concentrations, with citrate/creatinine values be-(Boehringer Mannheim, Mannheim, Germany), respec-
ing as low as 0.08 mol/mol. Median citrate/creatininetively. Creatinine concentration was determined by a
levels in the infants with NC increased from 0.52 forstandard kinetic Jaffe´ procedure.
week one to 1.91 mol/mol at week 8. In nine infants withBlood gas analyses were performed daily during the
NC the longitudinal follow-up showed urinary citrate/first 2 weeks of life and thereafter once a week or when
creatinine levels being generally lower (range, 0.08 toclinically indicated. Renal ultrasound examinations were
0.37 mol/mol) than those obtained in the whole studyperformed at least every second week and always by the
population and in those 1000 g. In addition, increasedsame pediatric radiologist (Prof. Dr. G. Benz-Bohm).
oxalate/creatinine and calcium/creatinine ratios wereHence, we were able to minimize the observer variability
reported for the sonographic diagnosis of nephrocal- found in five infants each and calcium/citrate ratios were
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Table 1. Clinical data, time of mechanical ventilation, and dosage of medication in preterm infants included in the study
Group A Group B Infants with
1000 g 1000–1500 g nephrocalcinosis (NC)
Number of infants 53 55 16
Gestation age weeks 26.4 (2.2)a 30.8 (1.0) 27.0 (1.8)a
Birth weight g 722 (156)a 1301 (157) 794 (271)a
Duration of ventilation days 8.611.2a 2.44.7 9.16.9a
Dexamethasone dosage mg/kg 1.04 (1.53)b 0.16 (0.62) 1.3 (1.29)a
Furosemide dosage mg/kg 2.83 (5.77)b 0.53 (1.54) 7.07 (18.1)b
Theophylline dosage mg/kg 62.6 (55.8)a 18.6 (21.8) 74.0 (49.1)a
Coffeincitrate dosage mg/kg 294 (194)a 118 (88.8) 276 (99.8)a
Mean ( SD).
aP  0.001, bP  0.05 (group A and infants with NC compared to group B, no statistical difference between group A and the infants with NC)
Table 2. Urinary calcium/creatinine (Ca/Cr), oxalate/creatinine (Ox/Cr), uric acid/creatinine (UA/Cr), citrate/creatinine (Cit/Cr), calcium/
citrate (Ca/Cit), and oxalate/citrate (Ox/Cit) ratios in very low birth weight (VLBW) infants (1000 g) in relation to age ( group A)
Age weeks
I II III IV V VI VII VIII
Ca/Cr mol/mol Median 0.78 1.48 1.40 1.55 1.00 1.16 1.80 1.33
Range 0.23–2.24 0.29–6.53 0.09–5.66 0.38–5.40 0.24–4.30 0.32–4.20 0.67–6.70 0.45–8.90
N 11 15 21 23 17 13 18 25
Ox/Cr mmol/mol Median 334 234 353 399 304 356 354 430
Range 191–619 43–605 159–1258 70–1448 42–1098 258–600 205–1552 190–1740
N 10 12 18 20 16 12 18 25
Cit/Cr mol/mol Median 0.70 0.40 0.65 1.10 1.32 1.88 1.61 2.16
Range 0.24–1.47 0.12–1.65 0.04–2.96 0.35–3.10 0.11–3.30 0.78–2.84 0.07–3.61 0.66–5.30
N 10 15 21 23 18 13 17 26
UA/Cr mol/mol Median 1.55 1.89 1.98 2.28 1.68 1.5 1.88 2.21
Range 1.01–2.24 0.61–2.19 1.24–4.00 0.67–3.91 1.19–3.39 0.88–2.36 1.46–2.74 1.46–3.07
N 5 6 6 9 8 5 8 11
Ca/Cit mol/mol Median 1.2 2.8 1.43 1.37 0.76 0.64 1.08 0.62
Range 0.55–2.92 0.59–17.5 0.25–33 0.16–6.1 0.30–6.78 0.15–5.32 0.41–41.3 0.14–7.83
N 10 15 21 23 17 13 17 26
Ox/Cit mol/mol Median 0.38 0.45 0.57 0.31 0.24 0.17 0.20 0.21
Range 0.18–1.29 0.11–1.82 0.17–5.00 0.16–1.79 0.08–3.53 0.11–0.40 0.10–8.02 0.06–1.77
N 8 12 18 20 16 12 17 25
Table 3. Urinary calcium/creatinine (Ca/Cr), oxalate/creatinine (Ox/Cr), uric acid/creatinine (UA/Cr), citrate/creatinine (Cit/Cr), calcium/
citrate (Ca/Cit), and oxalate/citrate (Ox/Cit) ratios in very low birth weight (VLBW) infants (1000 to 1500 g) in relation to age ( group B)
Age weeks
I II III IV V VI VII VIII
Ca/Cr mol/mol Median 0.82 0.96 1.36 0.87 1.12 1.47 1.84 3.23
Range 0.15–3.33 0.16–2.74 0.53–3.78 0.17–2.84 0.24–4.37 0.35–6.00 0.58–5.66 0.55–10.0
N 28 24 28 20 24 20 14 15
Ox/Cr mmol/mol Median 248 241 284 327 348 308 319 480
Range 100–1800 116–464 175–481 49–523 111–789 157–759 127–921 143–777
N 25 21 25 20 23 19 13 13
Cit/Cr mol/mol Median 0.70 0.86 1.38 1.74 1.78 2.15 2.76 2.66
Range 0.11–3.92 0.06–2.85 0.18–3.69 0.19–2.95 0.22–4.97 1.10–3.47 1.34–5.27 1.42–6.68
N 27 24 28 20 24 19 14 12
UA/Cr mol/mol Median 1.45 0.98 1.32 1.37 1.53 1.47 1.37 1.54
Range 0.38–10.4 0.58–1.73 0.57–1.61 0.21–2.54 0.73–2.29 0.95–2.23 0.88–2.58 1.01–2.23
N 14 14 14 13 15 11 11 10
Ca/Cit mol/mol Median 1.04 0.84 0.98 0.62 0.69 0.74 0.66 0.94
Range 0.22–6.29 0.25–8.70 0.29–9.52 0.09–2.54 0.14–1.46 0.19–3.01 0.38–1.43 0.24–3.48
N 27 24 28 20 24 20 14 11
Ox/Cit mol/mol Median 0.37 0.26 0.25 0.22 0.20 0.16 0.13 0.09
Range 0.07–1.80 0.07–4.06 0.07–2.33 0.02–1.26 0.06–1.92 0.05–0.41 0.04–0.27 0.06–0.49
N 24 21 25 20 24 18 13 9
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Fig. 1. Median urinary calcium/creatinine (Ca/Cr) (A), oxalate/creatinine (Ox/Cr) (B ), citrate/creatinine (Cit/Cr) (C ), uric acid/creatinine (UA/Cr)
(D ), calcium/citrate (Ca/Cit) (E ), and oxalate/citrate (Ox/Cit) (F ) ratios in very low birth weight (VLBW) infants with birth weight (BW) below
() and above () 1000 g during the first 8 weeks of life. *Statistical differences P  0.05.
elevated in nine infants with NC. However, the differ- to the lower GFR in immature kidneys. Another expla-
nation relates it to the lithogenic effect of specific treat-ence did not reach statistical significance due to the large
ment modalities that are primarily used in smaller andrange and the limited number of infants with NC. Birth
sicker preterm infants. Historically, furosemide-inducedweight was 1000 g in 13 of 16 infants with NC.
hypercalciuria was considered to be the main risk factor
for the development of NC [2, 6, 7], but subsequently
DISCUSSION other hypercalciuric agents like corticosteroids [16],
Preterm infants with a birth weight below 1500 g are methylxanthines [17], or parenteral nutrition [18] were
reported to be at risk for the development of NC, how- linked with this condition. An influence of parenteral
ever, the incidence appears to be especially high in in- nutrition on the development of hyperoxaluria was also
fants below 1000 g [1, 4, 13]. Of the 16 premature infants reported [18, 19]. Finally, the gestational age (or birth
with NC diagnosed in our department in the last 3 years, weight)–dependent imbalance between promotors and
13 (81%) had a birth weight below 1000 g, and the mean inhibitors of crystallization might play an additional role.
birth weight of 16 premature infants with NC born in However, this hypothesis has not been tested in a popula-
the previous period (1988 to 1998) was 1044 g [1]. In tion of very sick preterm infants. Our results show lower
accordance, the mean birth weight of infants with NC urinary citrate/creatinine ratios during the first 8 weeks
ranged between 800 g and 1100 g in the majority of studies of life in VLBW infants with a birth weight 1000 g
[4, 14, 15]. In addition, the preterm infants developing than in those with birth weights of 1000 to 1500 g. Be-
NC all had a gestational age 32 weeks [1]. So far, the cause citrate is a potent inhibitor of calcium oxalate
increased risk of NC in infants with a lower birth weight [20] and calcium phosphate [21] precipitation in urine,
is not fully explained. According to Schell-Feith et al hypocitraturia could play an important role in the patho-
[4, 10], it is the result of a higher susceptibility to hetero- genesis of NC in preterm infants as it does in stone
disease [22, 23].geneous crystallization and a reduced urine output due
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Lower citrate/creatinine ratios in smaller preterm in- oxalate did not differ between the two groups, except
for a significantly higher calcium/creatinine ratio at 4fants could also be due to a relatively higher creatinine
excretion. However, the opposite is the case, as the latter weeks in the smaller infants. Results of earlier studies
concerning these two main components of renal calcifi-increases significantly with postconceptional age [24].
Keeping in line is the finding of higher calcium/creatinine cation in infants with NC are conflicting [4, 5, 11, 28].
Some authors reported an increased calcium excretionand oxalate/creatinine ratios. In contrast, the citrate/cre-
atinine ratios in the younger infants are lower indicating [4, 11], whereas other did not find it [5]. Similarly, oxalate
excretions were reported to be increased [5, 28] or nor-that urinary citrate excretion is indeed reduced.
The pathogenesis of the lower citrate excretion is not mal [4]. This might be simply explained by the heteroge-
neity of the studied populations, especially with regardclear. A possible explanation could be a more pronounced
metabolic acidosis—one of the reasons for hypocitratu- to the medical care.
Although the analysis of the urinary excretion of litho-ria—in smaller preterm infants [25]. In accordance, Mur-
phy and Mendoza [26] found lower urinary citrate/creati- genic and inhibitory substances in VLBW infants is im-
portant, there are, apart from oxalate, no adjusted refer-nine ratios in premature infants with lung disease and
acidosis in comparison to nonacidotic controls. This re- ence values available [8]. Our data show that urinary
ratios of these parameters in VLBW infants depend bothsult may explain the strong relationship between the
duration of ventilation or oxygen dependency and the on birth weight and postnatal age.
Our results suggest that hypocitraturia is associatedincidence of NC reported by others [5, 11]. Hence, we
might speculate that the chance of more pronounced with an increased risk of NC in VLBW infants with a
birth weight 1000 g during the first 8 weeks of life.periods of acidosis was higher in group A and in the
infants with NC, as the duration of ventilation was sig- Supplementation with alkali citrate may therefore have
a beneficial effect in the prevention of NC in this popula-nificantly longer compared to group B. Repeated blood
gas analysis, however, did not express extended acidosis tion as is the case in calcium oxalate stone disease
[30–34]. However, the effect of prophylactic treatmentin these infants.
Citrate excretion could also simply be age dependent, with alkali citrate in extremely low birth weight infants
should first be examined in a controlled study.but we cannot exclude other influencing elements like
postnatal renal maturation, the clinical condition, and
the adaptation to nutritional and pharmacologic factors. ACKNOWLEDGMENTS
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